Serial angiographic findings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation

American Heart Journal

Volumn 160, Issue 4, 2010, Pages 775.e1-775.e9

  Ino, Yasushi ^a   Toyoda, Yasuaki ^a   Tanaka, Atsushi ^b   Ishii, Shuuta ^a   Kusuyama, Yoshio ^a   Kubo, Takashi ^b   Takarada, Shigeho ^b   Kitabata, Hironori ^b   Tanimoto, Takashi ^b   Hirata, Kumiko ^b   Mizukoshi, Masato ^b   Imanishi, Toshio ^b   Akasaka, Takashi ^b  

^a National Hospital Organization   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; FRACTURE; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STENT FRACTURE; STENT THROMBOSIS; CLINICAL TRIAL; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROCEDURES; PROGNOSIS; PROSTHESIS FAILURE; RADIOGRAPHY; RESTENOSIS; RETROSPECTIVE STUDY; TIME;

AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS;

EID: 77957849281     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.07.010     Document Type: Article

References (30)

1. Morice M.C., Serruys P.W., Sousa J.E. for the RAVEL Study Group A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
2. Moses J.W., Leon M.B., Popma J.J. for the SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
3. Colombo A., Orlic D., and Stankovic G. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation Circulation 107 2003 2178 2180
4. Lemos P.A., Saia F., and Ligthart J.M. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanical analysis from a consecutive series of cases Circulation 108 2003 257 260
5. Takebayashi H., Mintz G.S., and Carlier S.G. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation Circulation 110 2004 3430 3434
6. Nakazawa G., Fin A.V., and Vorpahl M. Incidence and predictors of drug-eluting stent fracture in human coronary artery J Am Coll Cardiol 54 2009 1924 1931
7. Lee S.H., Park J.S., and Shin D.G. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation Am J Cardiol 100 2007 627 630
8. Aoki J., Nakazawa G., and Tanabe K. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation Catheter Cardiovasc Interv 69 2007 380 386
9. Lee M.S., Jurewitz D., and Aragon J. Stent fracture associated with drug-eluting stents: clinical characteristics and implications Catheter Cardiovasc Interv 69 2007 387 394
10. Okumura M., Ozaki Y., and Ishii J. Restenosis and stent fracture following sirolimus-eluting stent (SES) implantation Circ J 71 2007 1669 1677
11. Umeda H., Gochi T., and Iwase M. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation Int J Cardiol 133 2009 321 326
12. Ino Y., Toyoda Y., and Tanaka A. Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation Circ J 73 2009 2036 2041
13. Liistro F., Stankovic G., and Mario C.D. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome Circulation 105 2002 1883 1886
14. Virmani R., Liistro F., and Stankovic G. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans Circulation 106 2002 2649 2651
15. Fajadet J., Morice M.C., and Bode C. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial Circulation 111 2005 1040 1044
16. Hong M.K., Mintz G.S., and Lee C.W. Late target lesion revascularization after implantation of sirolimus-eluting stent Catheter Cardiovasc Interv 71 2008 299 303
17. Cosgrave J., Corbett S.J., and Melzi G. Late restenosis following sirolimus-eluting stent implantation Am J Cardiol 100 2007 41 44 (Pubitemid 46961896)
18. Doi H., Maehara A., and Mintz G.S. Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture Am J Cardiol 103 2009 818 823
19. Popma J.J., Tiroch K., and Almonacid A. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation Am J Cardiol 103 2009 923 929
20. Cutlip D.E., Windecker S., and Mehran R. Academic research consortium. clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
21. Mehrle A., Skelton T., and Almonacid A. Stent fracture: an unusual cause of late restenosis after sirolimus-eluting stent placement Catheter Cardiovasc Interv 69 2007 989 992
22. Sianos G., Hofma S., and Ligthart J.M. Stent fracture and restenosis in the drug-eluting stent era Catheter Cardiovasc Interv 61 2004 111 116
23. Kimura T., Yokoi H., and Nakagawa Y. Three-year follow-up after implantation of metallic coronary-artery stents N Engl J Med 334 1996 561 566
24. Kuroda N., Kobayashi Y., and Nameki M. Intimal hyperplasia regression from 6 to 12 months after stenting Am J Cardiol 89 2002 869 872
25. Farb A., Heller P.F., and Shroff S. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent Circulation 104 2001 473 479
26. Park D.W., Hong M.K., and Mintz G.S. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study J Am Coll Cardiol 48 2006 2432 2439
27. Degertekin M., Serruys P.W., and Foley D.P. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up Circulation 106 2002 1610 1613
28. Sousa J.E., Costa M.A., and Sousa A.G. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries Circulation 107 2003 381 383
29. Sousa J.E., Costa M.A., and Abizaid A. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents Circulation 111 2005 2326 2329
30. Aoki J., Abizaid A.C., and Serruys P.W. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients J Am Coll Cardiol 46 2005 1670 1676